Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani
View: Text | PDF
Research Article Immunology

Hem-1 regulates protective humoral immunity and limits autoantibody production in a B cell–specific manner

  • Text
  • PDF
Abstract

Hematopoietic protein-1 (Hem-1) is a member of the actin-regulatory WASp family verprolin homolog (WAVE) complex. Loss-of-function variants in the NCKAP1L gene encoding Hem-1 were recently discovered to result in primary immunodeficiency disease (PID) in children, characterized by poor specific Ab responses, increased autoantibodies, and high mortality. However, the mechanisms of how Hem-1 deficiency results in PID are unclear. In this study, we utilized constitutive and B cell–specific Nckap1l-KO mice to dissect the importance of Hem-1 in B cell development and functions. B cell–specific disruption of Hem-1 resulted in reduced numbers of recirculating follicular (FO), marginal zone (MZ), and B1 B cells. B cell migration in response to CXCL12 and -13 were reduced. T-independent Ab responses were nearly abolished, resulting in failed protective immunity to Streptococcus pneumoniae challenge. In contrast, T-dependent IgM and IgG2c, memory B cell, and plasma cell responses were more robust relative to WT control mice. B cell–specific Hem-1–deficient mice had increased autoantibodies against multiple autoantigens, and this correlated with hyperresponsive BCR signaling and increased representation of CD11c+T-bet+ age-associated B cell (ABC cells) — alterations associated with autoimmune diseases. These results suggest that dysfunctional B cells may be part of a mechanism explaining why loss-of-function Hem-1 variants result in recurring infections and autoimmunity.

Authors

Alan Avalos, Jacob T. Tietsort, Nutthakarn Suwankitwat, Jonathan D. Woods, Shaun W. Jackson, Alexandra Christodoulou, Christopher Morrill, H. Denny Liggitt, Chengsong Zhu, Quan-Zhen Li, Kevin K. Bui, Heon Park, Brian M. Iritani

×

Figure 6

Conditional deletion of Hem-1 in B cells results in increased IgM and IgG2c Ab production in response to immunization with TD Ags.

Options: View larger image (or click on image) Download as PowerPoint
Conditional deletion of Hem-1 in B cells results in increased IgM and Ig...
Eight- to 10-week-old mice were immunized with 100 μg/mouse NP-KLH in alum via i.p. injection. (A–D) Shown are graphs depicting NP-specific IgM, IgG1, IgG3, and IgG2c production based on OD at 405 nm over a 4-week period after immunization. n = 5 mice per group. Each data point represents a single mouse and is representative of a single experiment. Data represent mean ± SEM and were analyzed via unpaired Student’s t test. *P < 0.05. (E–G) WT and Hem1fl/flMb1Cre mice were immunized with NP-KLH. Four weeks after immunization, mice were boosted with 20 μg/mouse NP-KLH in PBS. Seven days after boost, splenocytes were harvested and cells were stained for flow cytometric analyses. (E) Shown are representative dot plot histograms (left) and graphs with quantification of total plasma cells (B220–CD138+) (right) isolated from immunized WT and Hem1fl/flMb1Cre mice and unimmunized control mice. (F) Shown are representative dot plot histograms (left) and quantification of NP-specific plasma cells (B220–CD138+CD19–NP+) (right) from immunized WT and Hem1fl/flMb1Cre mice and unimmunized control mice. (G) Representative flow cytometric histograms and graphs with quantification of memory B cells (B220+IgD–CD38+CD19+NP+) from immunized WT, and Hem1fl/flMb1Cre mice and unimmunized control mice. (H) H&E-stained spleen sections from individual mice showing germinal center size (20× magnification) (left) and bar graphs depicting GC number/area and average GC area (right). Arrows denote the size of representative GCs. Each data point is representative of an individual mouse and is representative of a single experiment. Data represent mean ± SEM and were analyzed via unpaired Student’s t test. *P < 0.05, **P < 0.01, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts